Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
77
CDNA Quote, Financials, Valuation and Earnings
Last price:
$18.92
Seasonality move
:
-9.34%
Day range:
$18.36 - $19.00
52-week range:
$10.96 - $25.95
Dividend yield:
0%
P/E ratio:
15.54x
P/S ratio:
2.87x
P/B ratio:
3.06x
Volume:
639.1K
Avg. volume:
1M
1-year change:
-24.52%
Market cap:
$953M
Revenue:
$333.8M
EPS (TTM):
$1.19
Analysts' Opinion
-
Consensus RatingCareDx, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.33, CareDx, Inc. has an estimated upside of 20.53% from its current price of $18.90.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing 100% downside risk from its current price of $18.90.
Fair Value
-
According to the consensus of 8 analysts, CareDx, Inc. has 20.53% upside to fair value with a price target of $22.33 per share.
CDNA vs. S&P 500
-
Over the past 5 trading days, CareDx, Inc. has overperformed the S&P 500 by 3.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CareDx, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CareDx, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter CareDx, Inc. reported revenues of $100.1M.
Earnings Growth
-
CareDx, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter CareDx, Inc. reported earnings per share of $0.03.
Enterprise value:
786.5M
EV / Invested capital:
2.32x
Price / LTM sales:
2.87x
EV / EBIT:
--
EV / Revenue:
2.20x
PEG ratio (5yr expected):
-0.13x
EV / Free cash flow:
21.60x
Price / Operating cash flow:
28.18x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$239.6M
Return On Assets:
15%
Net Income Margin (TTM):
19.68%
Return On Equity:
21.1%
Return On Invested Capital:
19.41%
Operating Margin:
2.01%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $297.1M | $312.8M | $358M | $82.9M | $100.1M | |
| Gross Profit | $188.9M | $203.1M | $239.6M | $54.7M | $68.7M | |
| Operating Income | -$99M | -$67.5M | -$25.1M | -$13.7M | $2M | |
| EBITDA | -$80.3M | -$49.4M | -$6.3M | -$8.8M | $7.2M | |
| Diluted EPS | -$1.68 | -$2.89 | $1.19 | -$0.20 | $0.03 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $444.7M | $388.2M | $345.2M | $334.1M | $300.3M | |
| Total Assets | $563.2M | $544.5M | $501.2M | $477M | $432.3M | |
| Current Liabilities | $69.7M | $70.3M | $72.7M | $81.4M | $99M | |
| Total Liabilities | $91M | $107.8M | $107M | $203.7M | $121.2M | |
| Total Equity | $472.1M | $436.7M | $394.1M | $273.2M | $311.1M | |
| Total Debt | $17.9M | $34.7M | $29.3M | $23.8M | $21.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.8M | $7.8M | $42.6M | $12.5M | $37.4M | |
| Cash From Investing | $1.6M | $43M | $35M | -$14.4M | $12.3M | |
| Cash From Financing | -$5.1M | -$31.6M | -$81.8M | $1.4M | -$26.5M | |
| Free Cash Flow | -$13.7M | $1.2M | $36.4M | $10.8M | $35.4M | |
CDNA
Sector
Market Cap
$953M
$28.5M
Price % of 52-Week High
71.41%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
8.58%
-1.33%
1-Year Price Total Return
-24.98%
-20.32%
Beta (5-Year)
2.544
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$18.25
200-day SMA
Buy
Level
$16.39
Bollinger Bands (100)
Buy
Level
12.66 - 16.24
Chaikin Money Flow
Buy
Level
8.3M
20-day SMA
Buy
Level
$17.18
Relative Strength Index (RSI14)
Buy
Level
64.18
ADX Line
Buy
Level
31.76
Williams %R
Neutral
Level
-27.3118
50-day SMA
Buy
Level
$15.77
MACD (12, 26)
Buy
Level
0.92
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
96.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.74)
Buy
CA Score
(Annual)
Level (-0.0145)
Sell
Beneish M-Score
(Annual)
Level (-2.1879)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-4.9878)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
Stock Forecast FAQ
In the current month, CDNA has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CDNA average analyst price target in the past 3 months is $22.33.
-
Where Will CareDx, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CareDx, Inc. share price will rise to $22.33 per share over the next 12 months.
-
What Do Analysts Say About CareDx, Inc.?
Analysts are divided on their view about CareDx, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CareDx, Inc. is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is CareDx, Inc.'s Price Target?
The price target for CareDx, Inc. over the next 1-year time period is forecast to be $22.33 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CDNA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CareDx, Inc. is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CDNA?
You can purchase shares of CareDx, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CareDx, Inc. shares.
-
What Is The CareDx, Inc. Share Price Today?
CareDx, Inc. was last trading at $18.92 per share. This represents the most recent stock quote for CareDx, Inc.. Yesterday, CareDx, Inc. closed at $18.90 per share.
-
How To Buy CareDx, Inc. Stock Online?
In order to purchase CareDx, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CDNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CDNA
Sector
P/E ratio
15.54x
23.75x
PEG ratio
-0.13x
-0.01x
P/B ratio
3.06x
1.83x
Price / LTM sales
2.87x
1.60x
Growth Metrics
CDNA
Sector
Revenue growth
20.72%
4.85%
Earnings growth
115.52%
11.11%
Revenue (5-year growth)
21.31%
6.45%
Earnings forecast
$0.14
-$0.20
Profitability
CDNA
Sector
Profitability FY 2024
$221.6M
$3.6M
Return on invested capital
19.41%
-30.98%
Return on assets
15%
-27.62%
Return on equity
21.1%
-36.69%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
3
Balance Sheet
CDNA
Sector
Total cash
$194.2M
$27.2M
Short term investments
$146M
$25.7M
Total assets
$505.5M
$79.7M
Long term debt
$21.2M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Buy
72
KYMR alert for Dec 8
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
